Clinical feature and efficacy of patients with multiple myeloma and renal impairment treated with bortezomib based chemotherapy

Objective To explore the efficacy and safety of bortezomib(btz) based chemotherapy in multiple myeloma(MM) patients with renal-function impairment(RI).Methods Fifty-six MM patients with impaired renal